China's CN¥ 56.78 Billion Food-Medicine Homology Market in 2025
By Jessie Wang
5 min read
Executive Summary#
China's online food-medicine homology market reached CN¥ 56.78 billion in 2024, growing +5.2% YoY across Taobao (淘宝), Tmall (天猫), JD.com (京东), and Douyin (抖音). Sales volume hit 720 million units, driven by broadening consumer adoption of traditional Chinese medicine (TCM) wellness principles. However, the market's real story lies beneath the headline figure: a structural shift from premium traditional tonics toward affordable, condition-specific products is reshaping the competitive landscape. Average selling prices fell to CN¥ 78.4 as nearly 170,000 merchants competed across 2.55 million SKUs.
Astragalus surged +75.2% YoY to lead emerging ingredient growth, while established ingredients such as ginseng and cordyceps posted sharp declines. Ready-to-eat tonic social media buzz volume jumped +86.7% YoY, and gift box tonic sales grew +22.3% YoY, signaling a product format revolution driven by younger, convenience-seeking consumers.
Download Full Report#
For complete market sizing data, ingredient rankings, health segment analysis, and product trend forecasts, download the full whitepaper.
Download the Full 2025 Food-Medicine Homology Whitepaper →
A CN¥ 56.78 Billion Market Built on Cultural Heritage#
The food-medicine homology concept -- ingredients that serve both nutritional and medicinal purposes, as classified by China's National Health Commission -- sits at the intersection of TCM heritage and modern wellness demand. Nearly half of Chinese consumers (49%) express high interest in TCM health care approaches, with an additional 28% willing to try, creating a combined 77% addressable market.
Consumer health concerns align directly with TCM ingredient positioning. Low energy affects 42% of consumers, followed by mood disorders (38%) and sleep problems (36%). These lifestyle-related conditions drive demand for qi and blood nourishment ingredients such as ginseng, astragalus, and sour jujube seed.
The market's growth trajectory reflects this deep cultural resonance, but structural changes are underway. Average commodity prices declined from CN¥ 92.3 in 2022 to CN¥ 78.4 in 2024 as new market entrants competed on price. Product SKUs increased +45.7% to 2.55 million, while the merchant count stabilized near 170,000, suggesting early market consolidation where surviving merchants are broadening their product portfolios rather than the market seeing a continued influx of new sellers.
Demographic Shifts Signal Market Expansion#
The consumer base is undergoing a generational shift that will define the market's next phase. Women account for over 65% of food-medicine homology social media attention, reinforcing their role as household health decision-makers. More significantly, the under-35 age cohort's share increased by +4.1 percentage points, with the 26-30 and 31-35 age groups driving the bulk of this expansion.
This dual-demographic dynamic creates a two-track market opportunity. The 50+ segment remains the single largest age cohort at 19.3%, sustaining demand for premium traditional tonics. Meanwhile, younger consumers prefer ready-to-eat formats, social-media-validated products, and ingredients backed by accessible health claims.
Geographically, Tier 1 and new Tier 1 cities retain over 60% market share, but lower-tier cities are gaining ground. Tier 5 cities expanded from 5.7% to 6.8% of total attention, driven by improved logistics, rising disposable incomes, and exposure to food-medicine homology content through short-video platforms.
The Ingredient Shake-Up: Emerging Winners and Declining Premiums#
The ingredient landscape reveals a market in transition. Among the top 20 ingredients by sales, astragalus recorded +75.2% YoY growth, followed by chicken's gizzard-membrane (ji nei jin) at +55.0%, polygonatum at +45.6%, and angelica at +42.5%. These emerging ingredients address diverse health concerns from qi nourishment to digestive health.
At the other end, ginseng/garden ginseng declined -48.8% and cordyceps fell -30.6%. Both are premium-priced ingredients historically tied to luxury tonic gifting. Their decline signals consumer rebalancing toward more accessible, condition-specific alternatives.
Astragalus surges +75.2% while cordyceps and ginseng face significant decline
Health Segments: Where Chronic Condition Demand Drives Growth#
Three health segments illustrate the market's condition-specific growth trajectory.
The "three highs" segment (hypertension, hyperglycemia, hyperlipidemia) surpassed CN¥ 4.5 billion with +14.9% YoY growth, nearly triple the overall market rate. The high blood sugar sub-segment alone reached over CN¥ 1.5 billion with +25.7% YoY growth, driven by China's 140 million diabetic adults. Honeysuckle (+131.2%) and cinnamon (+98.9%) led explosive ingredient growth within this segment.
The liver care segment exceeded CN¥ 9.1 billion at +6.6% YoY, making it the second-largest health segment. White peony root achieved a remarkable +210.8% YoY increase, signaling a consumer preference shift from Western-origin liver supplements toward TCM alternatives.
The sleep aid segment reached CN¥ 624 million, with chrysanthemum (+181.8%) and schisandra (+178.5%) leading ingredient diversification beyond the dominant sour jujube seed.
Product Format Innovation Expands the Addressable Market#
Product innovation is broadening the food-medicine homology market beyond traditional tonics. Ready-to-eat tonic social media buzz surged +86.7% YoY, confirming consumer demand for convenient health product formats. Cross-category fusions with bakery, tea beverages, and prepared meals are embedding TCM ingredients into categories with significantly larger consumer bases.
Gift box tonic sales grew +22.3% YoY, nearly triple the overall tonic market's +7.6% growth. Brands such as Dong'e Ejiao (东阿阿胶) leverage cultural IP and premium packaging to capture the high-value gift economy. The Taohua Ji series, inspired by the classical "Classic of Mountains and Seas" (Shanhai Jing), exemplifies how cultural storytelling commands price premiums in this segment.
Related Insights#
- Astragalus, Ji Nei Jin, and the Ingredient Shake-Up Reshaping China's TCM Market
- Ready-to-Eat Tonics and Gift Box Innovation Drive China's TCM Product Revolution
About the Data#
This analysis draws on Moojing Market Intelligence's proprietary transaction data from major Chinese online platforms. Ingredient classification references the National Health Commission's official food-medicine homology ingredient lists. Social media metrics derive from analysis of consumer discussions across mainstream Chinese platforms. All growth rates are calculated on a year-on-year basis using consistent category definitions across the 2022-2024 period.
For methodology details, data sourcing, and complete market analysis, download the full report.
This content adheres to Moojing's editorial standards .
Frequently Asked Questions
CN¥ 56.78 billion in 2024, growing +5.2% year on year on 720 million units. The headline understates what is happening underneath it. Average selling prices moved from CN¥ 92.3 in 2022 to CN¥ 78.4 in 2024 as new entrants competed on price, while SKUs rose +45.7% to 2.55 million against a merchant count that stabilised near 170,000. Read together that is not a market flooded with new sellers — it is one where surviving merchants are broadening their ranges, which is an early consolidation signal rather than a fragmentation one, and it changes what a new entrant is actually competing against.
Broadly. 49% express high interest in traditional Chinese medicine health approaches and a further 28% are willing to try, giving a combined 77% addressable base. What they are buying against is specific and lifestyle-driven: low energy affects 42% of consumers, mood concerns 38% and sleep problems 36% — the conditions that map directly onto qi and blood nourishment ingredients such as ginseng, astragalus and sour jujube seed. The practical consequence is that the category does not have to teach consumers the concept, only connect a named concern to a named ingredient, which is a far shorter path to purchase than most wellness categories enjoy.
Among the leading ingredients by sales, astragalus grew +75.2%, chicken's gizzard-membrane (ji nei jin) +55.0%, polygonatum +45.6% and angelica +42.5%. Moving the other way, ginseng contracted -48.8% and cordyceps -30.6%. The pattern is not random: the two contracting ingredients are the premium-priced ones historically tied to luxury tonic gifting, while the four growing ones are accessible and condition-specific. Consumers are rebalancing away from ingredients bought for what they signal and toward ingredients bought for what they are meant to address — which changes both the price architecture and the claim a product has to make.
Chronic-condition segments, at rates well above the market. The "three highs" segment — hypertension, hyperglycaemia and hyperlipidaemia — passed CN¥ 4.5 billion at +14.9%, nearly triple the overall market rate, with the high blood sugar sub-segment alone above CN¥ 1.5 billion at +25.7% against a population of 140 million diabetic adults; honeysuckle (+131.2%) and cinnamon (+98.9%) led ingredient growth inside it. Liver care is the second-largest segment at CN¥ 9.1 billion (+6.6%), where white peony root grew +210.8% as buyers moved from Western-origin liver supplements toward TCM alternatives. Sleep aid reached CN¥ 624 million, with chrysanthemum (+181.8%) and schisandra (+178.5%) broadening it beyond sour jujube seed.
